International Journal of Medicine and Data

Objective To observe the clinical effect of acupoint catgut embedding on diuretic resistance in patients with heart failure, and the influence of NT‐pro BNP and AQP2 expression. Methods 64 patients with diuretic resistance in chronic heart failure were randomly divided into treatment group and control group. Both groups received routine western medicine treatment, while the treatment group received routine western medicine treatment plus acupoint catgut embedding treatment. Clinical efficacy, 24-hour urine volume, plasma N-terminal pro-brain natriuretic peptide (NT-pro BNP) level and AQP2 expression were compared between the two groups after 10 days of continuous treatment. Results: After treatment, the effective rate of the treatment group was higher than that of the control group, and the difference was statistically significant (P < 0.05). The 24-hour urine output of the two groups was significantly higher than that before treatment, and the difference was statistically significant (P<0.05). The levels of NT‐pro BNP and AQP2 in the treatment group were lower than those before treatment, and the differences were statistically significant (P < 0.05). However, although the ratio of the control group decreased, the difference was not statistically significant (P>0.05). Conclusion: For the treatment of heart failure patients with diuretic resistance, acupoint catgut embedding therapy has a significant clinical effect, which can effectively improve symptoms, promote urination, improve diuretic resistance and improve clinical efficacy.

Catgut embedding at acupoints; Heart failure; Diuretic resistance